ClinicalTrials.Veeva

Menu

Postoperative Pain Management After Minimally Invasive Esophagectomy (MIEPVBEA)

Sun Yat-sen University logo

Sun Yat-sen University

Status and phase

Unknown
Phase 4

Conditions

Esophageal Cancer

Treatments

Other: continuous epidural infusion
Other: combined paravertebral infusion and single shot of TAP block

Study type

Interventional

Funder types

Other

Identifiers

NCT02042313
20131015A

Details and patient eligibility

About

Esophagectomy is a major surgical procedure often associated with significant morbidity and mortality and significant level of postoperative pain. In contrast to open esophagectomy where epidural pain control has been considered as a gold standard and could be crucial in affecting outcome the analgesic scheme for minimally invasive esophagectomy (MIE) is yet to be established. We would like to compare continuous epidural analgesia and continuous paravertebral block combined with single shot subcostal transversus abdominis plane (TAP) block in the analgesic effects, levels of cytokines, and postoperative complications in patients receiving MIE.

Enrollment

58 estimated patients

Sex

All

Ages

20 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient has a physical status between ASA I and III
  • 20 - 75 years of age
  • Patient has signed an informed consent
  • Without contraindication of GA, EA or PVB

Exclusion criteria

  • ASA > III
  • Inability to provide informed consent
  • Bleeding disorders
  • Being pregnant
  • Contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs),
  • Allergy to amide-type local anesthetics or NSAIDs
  • Infection at the thoracic paravertebral injection site
  • Severe spine or chest wall deformity
  • Patients with major psychosis or drug and alcohol abuse
  • Patients with a history of significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic disease
  • Patients with physical disability that precludes complete cooperation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

58 participants in 2 patient groups

Epidural
Active Comparator group
Description:
Epidural catheters will be applied at the T6-8 level prior to the induction. 6 ml of 2% xylocaine with 1 in 200,000 epinephrine administered before surgery. During the surgery, 2% xylocaine with 1 in 200,000 epinephrine infusion will be administered at a rate of 2-10 ml/hour adjusted according to patient's blood pressure. After surgery, 0.125% levobupivacaine with 2.5μg fentanyl and 1 in 400,000 epinephrine will be given at a rate of 0.10-0.15 ml kg-1 h-1 (0.5 h lock and 2 ml bolus) through a patient-controlled infusion pump.
Treatment:
Other: continuous epidural infusion
combined PVB TAP
Experimental group
Description:
Paravertebral catheterization into the paravertebral region ipsilateral to the VATS incision as described by Murata at the level of T7-8 will be performed. 10 ml of 2% xylocaine with 1 in 200,000 epinephrine to initiate analgesia. During the surgery, 2% xylocaine with 1 in 200,000 epinephrine infusion will be administered at a rate of 2-10 ml/hour adjusted according to patient's blood pressure. After the surgery, 0.125% levobupivacaine with 2.5μg fentanyl and 1 in 400,000 epinephrine will be administered at the rate of 0.10-0.15 ml kg-1 h-1 (0.5 h lock and 2 ml bolus) through a patient-controlled infusion pump. Ultrasound-guided (USG) subcostal TAP block will be performed at the end of surgery. Fifteen milliliters of 0.5% levobupivacaine with 1 in 400,000 epinephrine will be injected in incremental doses on each side of the abdomen.
Treatment:
Other: combined paravertebral infusion and single shot of TAP block

Trial contacts and locations

1

Loading...

Central trial contact

Nai Liang Li, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems